SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040998
Filing Date
2023-08-10
Accepted
2023-08-10 09:00:57
Documents
48
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-20230630.htm   iXBRL 10-Q 1323156
2 EX-10.1 evok-ex10_1.htm EX-10.1 45038
3 EX-31.1 evok-ex31_1.htm EX-31.1 17273
4 EX-31.2 evok-ex31_2.htm EX-31.2 17675
5 EX-32.1 evok-ex32_1.htm EX-32.1 11745
6 EX-32.2 evok-ex32_2.htm EX-32.2 12781
7 GRAPHIC img215259106_0.jpg GRAPHIC 147334
  Complete submission text file 0000950170-23-040998.txt   4527075

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evok-20230630_pre.xml EX-101.PRE 168401
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evok-20230630.xsd EX-101.SCH 31008
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evok-20230630_lab.xml EX-101.LAB 245448
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evok-20230630_def.xml EX-101.DEF 82445
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evok-20230630_cal.xml EX-101.CAL 22275
42 EXTRACTED XBRL INSTANCE DOCUMENT evok-20230630_htm.xml XML 583198
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 231157426
SIC: 2834 Pharmaceutical Preparations